BRPI0924460A2 - composição farmacêutica para uso em oftalmologia médica e veterinária - Google Patents
composição farmacêutica para uso em oftalmologia médica e veterináriaInfo
- Publication number
- BRPI0924460A2 BRPI0924460A2 BRPI0924460-3A BRPI0924460A BRPI0924460A2 BR PI0924460 A2 BRPI0924460 A2 BR PI0924460A2 BR PI0924460 A BRPI0924460 A BR PI0924460A BR PI0924460 A2 BRPI0924460 A2 BR PI0924460A2
- Authority
- BR
- Brazil
- Prior art keywords
- medical
- pharmaceutical composition
- veterinary ophthalmology
- ophthalmology
- veterinary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/001—Dyes containing an onium group attached to the dye skeleton via a bridge
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2009/000295 WO2010143990A1 (ru) | 2009-06-10 | 2009-06-10 | Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0924460A2 true BRPI0924460A2 (pt) | 2018-03-27 |
Family
ID=43309061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0924460-3A BRPI0924460A2 (pt) | 2009-06-10 | 2009-06-10 | composição farmacêutica para uso em oftalmologia médica e veterinária |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9724313B2 (pt) |
| EP (2) | EP2441453B1 (pt) |
| JP (1) | JP5659388B2 (pt) |
| KR (1) | KR101478728B1 (pt) |
| CN (2) | CN102548548B (pt) |
| AU (1) | AU2009347921B8 (pt) |
| BR (1) | BRPI0924460A2 (pt) |
| CA (1) | CA2764481C (pt) |
| EA (1) | EA025414B1 (pt) |
| ES (1) | ES2527791T3 (pt) |
| IL (1) | IL216702A0 (pt) |
| MX (1) | MX2011013150A (pt) |
| UA (1) | UA104320C2 (pt) |
| WO (1) | WO2010143990A1 (pt) |
| ZA (1) | ZA201200111B (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012167236A1 (en) * | 2011-06-03 | 2012-12-06 | Mitotech Sa | Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
| CN102327650B (zh) * | 2011-08-25 | 2014-01-22 | 高家旗 | 一种人工晶状体植入手术柔性水溶胶辅剂及其制备方法 |
| RU2506086C1 (ru) * | 2012-09-07 | 2014-02-10 | Илья Александрович Марков | Глазные капли, обладающие противовоспалительным и антибактериальным действием |
| ES2846724T3 (es) * | 2012-12-19 | 2021-07-29 | Novartis Ag | Formulaciones de inhibidores de LFA-1 |
| RU2510264C1 (ru) * | 2012-12-21 | 2014-03-27 | Станислав Анатольевич Кедик | Офтальмологический препарат в виде глазных капель, содержащий разветвленные полигексаметиленгуанидины |
| CN103405766B (zh) * | 2013-08-06 | 2016-01-06 | 温州医学院眼视光研究院 | 一种贝伐单抗滴眼液及其制备方法 |
| US9308165B2 (en) * | 2013-08-22 | 2016-04-12 | Therapeutic Vision, Inc. | Composition for treating ocular effects of diabetes |
| US10617763B2 (en) | 2013-08-28 | 2020-04-14 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
| US10064818B2 (en) | 2013-08-28 | 2018-09-04 | Presbyopia Therapies, LLC | Compositions and methods for the treatment of presbyopia |
| US9320709B2 (en) | 2013-08-28 | 2016-04-26 | Presbyopia Therapies Llc | Storage stable compositions and methods for the treatment of refractive errors of the eye |
| US9089562B2 (en) * | 2013-08-28 | 2015-07-28 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9968594B2 (en) | 2013-08-28 | 2018-05-15 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9844537B2 (en) | 2013-08-28 | 2017-12-19 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US10307408B2 (en) | 2013-08-28 | 2019-06-04 | Presbyopia Therapies, LLC | Contact lens compositions and methods for the treatment of presbyopia |
| US9833441B2 (en) | 2013-08-28 | 2017-12-05 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US9314427B2 (en) | 2013-08-28 | 2016-04-19 | Presbyopia Therapies Llc | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye |
| US11179327B2 (en) | 2013-08-28 | 2021-11-23 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
| RU2533276C1 (ru) * | 2013-10-09 | 2014-11-20 | Станислав Анатольевич Кедик | Глазные капли на основе композиции фармацевтически приемлемой аддитивной соли кислоты и метилэтилпиридинола и таурина, содержащие композицию витаминов группы в |
| RU2528912C1 (ru) * | 2013-10-09 | 2014-09-20 | Станислав Анатольевич Кедик | Глазные капли на основе композиции фармацевтически приемлемой аддитивной соли кислоты и метилэтилпиридинола, содержащие композицию витаминов группы в |
| EP3116470B1 (en) * | 2014-02-25 | 2019-05-08 | Mitotech SA | Cosmetic compositions of mitochondrially targeted antioxidants |
| CN106794158A (zh) * | 2014-05-30 | 2017-05-31 | 劳伦斯·T·弗里霍夫 | 具有多重抗药性抑制性质的抗微生物药物组合物 |
| WO2016013993A1 (en) * | 2014-07-25 | 2016-01-28 | Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. | Stable preservative free ophthalmic formulations of opioid antagonists |
| WO2016200364A1 (en) * | 2015-06-08 | 2016-12-15 | Stealth Peptides International, Inc. | THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF |
| CN107312194A (zh) * | 2017-07-13 | 2017-11-03 | 温州嘉泰乳胶制品有限公司 | 乳胶固化配方工艺 |
| WO2019204401A1 (en) * | 2018-04-19 | 2019-10-24 | Presbyopia Therapies Llc | Compositions and methods for the treatment of presbyopia |
| US20210251970A1 (en) | 2018-10-10 | 2021-08-19 | Presbyopia Therapies Inc | Compositions and methods for storage stable ophthalmic drugs |
| CN111351886B (zh) * | 2018-12-24 | 2023-06-23 | 成都平和安康医药科技有限公司 | 一种测定酚磺乙胺药物中含有的杂质及其主药含量的方法 |
| US20230038070A1 (en) * | 2019-12-10 | 2023-02-09 | Mitotech S.A. | Polymer matrixes for different compositions of mitochondrially targeted antioxidants |
| EP4125867A1 (en) * | 2020-04-03 | 2023-02-08 | Mitotech S.A. | Use of mitochondria-targeted antioxidants to treat severe inflammatory conditions |
| RU2768752C1 (ru) * | 2020-12-24 | 2022-03-24 | Общество с ограниченной ответственностью "Международная лаборатория "Резистом" | Противовирусная композиция для защиты растений на основе поли(а):поли(у) |
| US12180206B2 (en) | 2021-11-17 | 2024-12-31 | Lenz Therapeutics Operations, Inc. | Aceclidine derivatives, compositions thereof and methods of use thereof |
| US11648247B1 (en) | 2021-12-16 | 2023-05-16 | Lenz Therapeutics, Inc. | Compositions and methods for the treatment of presbyopia |
| CN116270630A (zh) * | 2023-04-03 | 2023-06-23 | 爱尔眼科医院集团股份有限公司 | 巴马汀在制备治疗眼部疾病的药物中的用途 |
| US12414942B1 (en) | 2024-03-15 | 2025-09-16 | Lenz Therapeutics Operations, Inc. | Compositions, methods, and systems for treating presbyopia |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538974A (en) * | 1994-01-27 | 1996-07-23 | Senju Pharamceutical Co., Ltd. | Ophthalmic composition for lowering intraocular pressure |
| JPH07252149A (ja) * | 1994-01-27 | 1995-10-03 | Senju Pharmaceut Co Ltd | 眼科用剤 |
| US5535974A (en) * | 1994-03-07 | 1996-07-16 | Savitski; Richard H. | Scaffold bracket |
| US6331532B1 (en) | 1998-11-25 | 2001-12-18 | University Of Otago | Mitochondrially targeted antioxidants |
| WO1999026582A2 (en) | 1997-11-25 | 1999-06-03 | University Of Otago | Mitochondrially targeted compounds |
| US20080275005A1 (en) | 1998-11-25 | 2008-11-06 | Murphy Michael P | Mitochondrially targeted antioxidants |
| US20070270381A1 (en) | 2000-05-25 | 2007-11-22 | Antipodean Pharmaceuticals, Inc. | Mitochondrially targeted antioxidants |
| JP2001172183A (ja) * | 1999-12-21 | 2001-06-26 | Wakamoto Pharmaceut Co Ltd | 眼科用医薬組成物 |
| US20020044913A1 (en) | 2000-02-11 | 2002-04-18 | Hamilton Nathan D. | Cosmetics to support skin metabolism |
| JP4859283B2 (ja) * | 2001-05-23 | 2012-01-25 | 学校法人近畿大学 | 高安定性抗白内障医薬組成物 |
| ITRM20010755A1 (it) | 2001-12-20 | 2003-06-20 | Simonelli Giuseppe | Uso del chinone q10 per il trattamento delle malattie oculari. |
| US6984636B2 (en) | 2002-08-12 | 2006-01-10 | Medical Research Council | Mitochondrially targeted antioxidants |
| CN1839142B (zh) * | 2003-08-22 | 2010-06-16 | 澳新制药公司 | 用作靶向线粒体的抗氧化剂的线粒体醌衍生物 |
| CA2580584C (en) | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| WO2006005759A2 (en) | 2004-07-13 | 2006-01-19 | Oridis Biomed Forschungs- Und Entwicklungs Gmbh | Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| US20070259908A1 (en) | 2004-08-30 | 2007-11-08 | Kaneka Corporation | Mitochondria Activators |
| RU2318500C2 (ru) | 2005-10-18 | 2008-03-10 | Общество С Ограниченной Ответственностью "Митотехнология" | Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели |
| EP2119436A4 (en) * | 2006-10-20 | 2010-03-03 | Ltd Liability Company Mitotech | PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES |
| US8518915B2 (en) | 2007-06-29 | 2013-08-27 | Mitotech Sa | Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| JP2009091175A (ja) * | 2007-10-04 | 2009-04-30 | Sumitomo Electric Ind Ltd | ＧａＮエピタキシャル基板、半導体デバイス、ＧａＮエピタキシャル基板及び半導体デバイスの製造方法 |
| WO2009158348A1 (en) | 2008-06-25 | 2009-12-30 | Edison Pharmaceuticals, Inc. | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| MX2011011310A (es) * | 2009-04-28 | 2011-11-18 | Edison Pharmaceuticals Inc | Formulacion de tocotrienol quinonas para el tratamiento de enfermedades oftalmicas. |
-
2009
- 2009-06-10 CN CN200980159826.XA patent/CN102548548B/zh active Active
- 2009-06-10 EP EP09845897.9A patent/EP2441453B1/en active Active
- 2009-06-10 KR KR1020127000649A patent/KR101478728B1/ko active Active
- 2009-06-10 CA CA2764481A patent/CA2764481C/en active Active
- 2009-06-10 MX MX2011013150A patent/MX2011013150A/es active IP Right Grant
- 2009-06-10 EP EP14187905.6A patent/EP2823814A1/en not_active Ceased
- 2009-06-10 ES ES09845897.9T patent/ES2527791T3/es active Active
- 2009-06-10 UA UAA201200325A patent/UA104320C2/ru unknown
- 2009-06-10 JP JP2012514912A patent/JP5659388B2/ja active Active
- 2009-06-10 CN CN201710668350.9A patent/CN107362157B/zh active Active
- 2009-06-10 BR BRPI0924460-3A patent/BRPI0924460A2/pt not_active Application Discontinuation
- 2009-06-10 EA EA201101518A patent/EA025414B1/ru not_active IP Right Cessation
- 2009-06-10 AU AU2009347921A patent/AU2009347921B8/en not_active Ceased
- 2009-06-10 WO PCT/RU2009/000295 patent/WO2010143990A1/ru not_active Ceased
-
2011
- 2011-11-30 IL IL216702A patent/IL216702A0/en unknown
- 2011-12-09 US US13/315,397 patent/US9724313B2/en active Active
-
2012
- 2012-01-06 ZA ZA2012/00111A patent/ZA201200111B/en unknown
-
2017
- 2017-07-12 US US15/648,314 patent/US10213392B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102548548A (zh) | 2012-07-04 |
| CA2764481C (en) | 2015-11-24 |
| CN102548548B (zh) | 2017-09-01 |
| CN107362157B (zh) | 2022-08-26 |
| MX2011013150A (es) | 2012-03-14 |
| JP2012529504A (ja) | 2012-11-22 |
| KR20130082069A (ko) | 2013-07-18 |
| US10213392B2 (en) | 2019-02-26 |
| ZA201200111B (en) | 2012-09-26 |
| US20170304225A1 (en) | 2017-10-26 |
| AU2009347921A1 (en) | 2012-01-19 |
| CN107362157A (zh) | 2017-11-21 |
| WO2010143990A1 (ru) | 2010-12-16 |
| AU2009347921B8 (en) | 2014-07-24 |
| ES2527791T3 (es) | 2015-01-29 |
| UA104320C2 (ru) | 2014-01-27 |
| KR101478728B1 (ko) | 2015-01-02 |
| IL216702A0 (en) | 2012-02-29 |
| EP2441453A4 (en) | 2013-04-10 |
| EA201101518A1 (ru) | 2012-04-30 |
| EP2441453A1 (en) | 2012-04-18 |
| EP2823814A1 (en) | 2015-01-14 |
| US20120094962A1 (en) | 2012-04-19 |
| AU2009347921B2 (en) | 2014-07-17 |
| EA025414B1 (ru) | 2016-12-30 |
| JP5659388B2 (ja) | 2015-01-28 |
| EP2441453B1 (en) | 2014-11-26 |
| CA2764481A1 (en) | 2010-12-16 |
| US9724313B2 (en) | 2017-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011013150A (es) | Composicion farmaceutica para uso en oftalmologia medica y veterinaria. | |
| UY30373A1 (es) | Derivados de fenilalanina, procedimientos de preparacion y aplicaciones | |
| CY1118661T1 (el) | Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων | |
| EA021275B9 (ru) | Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания | |
| BR112015014372A8 (pt) | inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas". | |
| MA32200B1 (fr) | Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation | |
| DOP2011000343A (es) | Derivados de piridina tieno [2,3-b] como inhibidores de replicacion viral | |
| BR112015007814A2 (pt) | diagnóstico, prevenção e tratamento de doenças da articulação | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| CU24065B1 (es) | Forma de dosificación farmacéutica que comprende nifedipino y un antagonista de angiotensina ii | |
| BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
| WO2011116139A3 (en) | Improved pharmaceutical compositions comprising cck- 8 and methods of delivery | |
| WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
| MX340985B (es) | Compuestos de n-heteroarilo. | |
| CU20140037A7 (es) | Derivados de estra- 1,3,5(10), 16- tetraen- 3- carboximida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
| WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
| PE20150353A1 (es) | Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos | |
| CR20110704A (es) | Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amilodipina, su preparación y su aplicación terapéutica | |
| WO2012158405A3 (en) | Compositions and methods for the treatment of skin diseases | |
| WO2011091000A3 (en) | Oral care compositions and methods | |
| EA201170108A1 (ru) | Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки | |
| WO2008043788A3 (en) | Novel compounds | |
| IL217519A (en) | Tazarotene derivatives, pharmaceutical compositions comprising them and use thereof for the manufacture of medicaments for the treatment of skin disorders | |
| MX364652B (es) | Formulacion farmaceutica que comprende ciclesonida. | |
| BRPI1009003A2 (pt) | "método para expressão recombinante de um ccn1 humano, uso de um ccn1 humano, anticorpo contra ccn1 humano, uso de um anticorpo contra ccn1 humano, método para a fabricação de um medicamento para o tratamento de doenças e composição farmacêutica" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |